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Voxel based morphometryValid screening devices are critical for an early diagnosis of dementia. The DemTect is such an internationally
accepted tool. We aimed to characterize the neural networks associated with performance on the DemTect's
subtests in two frequent dementia syndromes: early Alzheimer's disease (AD) and frontotemporal lobar
degeneration (FTLD). Voxel-based group comparisons of cerebral glucose utilization (as measured by
F-18-ﬂuorodeoxyglucose positron emission tomography) and gray matter atrophy (as measured by structural
magnetic resonance imaging)were performed on data from48 subjectswith AD (n = 21), FTLD (n = 14) or sub-
jective cognitive impairment (n = 13) as a control group.We performed group comparisons and correlation anal-
yses between multimodal imaging data and performance on the DemTect's subtests. Group comparisons showed
regional patterns consistent with previous ﬁndings for AD and FTLD. Interestingly, atrophy dominated in FTLD,
whereas hypometabolism in AD. Across diagnostic groups performance on the “wordlist” subtest was positively
correlated with glucose metabolism in the left temporal lobe. The “number transcoding” subtest was signiﬁcantly
associated with glucose metabolism in both a predominantly left lateralized frontotemporal network and a
parietooccipital network including parts of the basal ganglia. Moreover, this subtest was associated with gray
matter density in an extensive network including frontal, temporal, parietal and occipital areas. No signiﬁcant cor-
relateswere observed for the “supermarket task” subtest. Scores on the “digit span reverse” subtest correlatedwith
glucose metabolism in the left frontal cortex, the bilateral putamen, the head of caudate nucleus and the anterior
insula. Disease-speciﬁc correlation analyses could partly verify or extend the correlates shown in the analyses
across diagnostic groups. Correlates of gray matter density were found in FTLD for the “number transcoding”
subtest and the “digit span reverse” subtest. Correlates of glucose metabolismwere found in AD for the “wordlist”
subtest and in FTLD for the “digit span reverse” subtest. Our study contributes to the understanding of the neural
correlates of cognitive deﬁcits in AD and FTLD and supports an external validation of the DemTect providing pre-
liminary conclusions about disease-speciﬁc correlates.
© 2013 The Authors. Published by Elsevier Inc. All rights reserved.ysis of variance; BA, Brodmann
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Today, dementia disorders are a major health problem — affecting
about 35.6 million people worldwide in 2010 (World Health
Organisation, 2012). An early diagnosis is crucial to identify
dementia-related diseases and administer appropriate therapeutic
interventions; valid clinical screening and treatment progression
devices are necessary to investigate speciﬁcally impaired cognitive
domains. One of the most important and frequently used clinical
dementia screening devices is the DemTect (Kalbe et al., 2004),
which has obtained international acceptance as a neuropsychologicalserved.
Table 1
Demographic and clinical characteristics of the patient groups.
AD FTLD Control Group
difference
Whole group
N 21 14 13 –
Age 61.1 ± 6.7 60.8 ± 6.4 53.9 ± 6.0 5.8, 2, 0.006a
Sex (f/m) 12/9 7/7 6/7 0.4, 2, 0.809b
Education (years) 10.7 ± 3.1 11.6 ± 3.8 12.3 ± 3.1 1.0, 2, 0.368a
CDR 0.7 ± 0.3 0.8 ± 0.4 0.2 ± 0.3 13.9, 2, 0.000a
MMSEc 23.2 ± 3.9 24.4 ± 4.2 28.8 ± 1.3 4.5, 2, 0.019a
DemTect group
N 14 9 6 –
Age 61.5 ± 7.6 59.3 ± 7.4 51.2 ± 7.6 3.9, 2, 0.032a
Sex (f/m) 9/5 5/4 2/4 1.6, 2, 0.443b
Education (years) 11.1 ± 3.2 10.9 ± 3.5 13.0 ± 3.3 0.9, 2, 0.427a
CDR 0.8 ± 0.3 0.8 ± 0.3 0.3 ± 0.3 10.3, 2, 0.001a
MMSEc 24.3 ± 3.8 23.8 ± 4.3 28.0 ± 1.0 1.4, 2, 0.263 a
DemTect sum score 7.9 ± 3.4 7.3 ± 5.8 15.5 ± 2.9 8.3, 2, 0.002a
DemTect subscoresd
Wordlist 1.43 ± 1.22 1.11 ± 1.05 2.67 ± 0.52 4.1, 2, 0.028a
Number transcoding 1.64 ± 0.93 1.67 ± 1.32 2.50 ± 0.55 1.7, 2, 0.209a
Supermarket task 1.71 ± 1.27 1.00 ± 1.41 4.00 ± 0.00 12.0, 2, 0.000a
Digit span reverse 2.21 ± 0.98 1.89 ± 0.93 2.50 ± 0.84 0.8, 2, 0.462a
Wordlist
(delayed recall)
0.86 ± 0.77 1.67 ± 2.06 3.83 ± 1.84 8.3, 2, 0.002a
Note. All values given in mean ± standard deviation. AD = Alzheimer's disease, CDR =
clinical dementia rating scale (Hughes et al., 1982), f = female, FTLD = frontotemporal
lobar degeneration, m = male, MMSE = Mini-Mental State Examination (Folstein et al.,
1975), n = total number.
a As tested with One-Way ANOVA: F, degrees of freedom (df), p.
b As tested with two-tailed chi-square test: chi-square, df, p.
c For twelve/four subjects MMSE was not available.
d Transformed scores.
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DemTect consists of ﬁve subtests: learning of a ten item wordlist in
two trials (“wordlist”), transcoding numbers in numerals and
vice-versa (“number transcoding”), a semantic word ﬂuency task (“su-
permarket task”), a task inwhich the patient has to repeat sequences of
numbers in backward order (“digit span reverse”), and ﬁnally the
wordlist's delayed recall (“wordlist, delayed recall”). In comparison to
the more established Mini-Mental State Examination (MMSE)
(Folstein et al., 1975), the DemTect has been shown to be superior in
several studies (Kalbe et al., 2004; Perneczky, 2003), especially
concerning the detection of mild dementia, which is a well-known
weakness of the MMSE (Simard, 1998). Although the neural correlates
of the MMSE have been investigated in studies with magnetic reso-
nance imaging (MRI) (Apostolova et al., 2006; Baxter et al., 2006;
Ferrarini et al., 2008; Jack et al., 2002; Nickl-Jockschat et al., 2011) and
F-18-ﬂuorodeoxyglucose positron emission tomography (FDG-PET)
(Mielke et al., 1994), these studies described neural correlates of total
MMSE scores only. In order to link dementia syndromes to underlying
impairments in neural networks, investigation of subtests addressing
speciﬁc cognitive domains is necessary.
The neural networks affected by neurodegenerative diseases,
especially Alzheimer's disease (AD) (Barnes et al., 2007; Baron et al.,
2001; Boxer et al., 2003; Buckner et al., 2005; Chetelat et al., 2008;
Frisoni et al., 2002; Rabinovici et al., 2007; Schroeter et al., 2009;
Seeley et al., 2009) and frontotemporal lobar degeneration (FTLD)
(Barnes et al., 2007; Boxer et al., 2003; Chetelat et al., 2008;
Desgranges et al., 2007; Ishii et al., 1998; Jeong et al., 2005;
Mummery et al., 2000; Rabinovici et al., 2007; Rosen et al., 2002;
Schroeter et al., 2008, 2011; Seeley et al., 2009), have been described
thoroughly in recent years in several studies and meta-analyses
(Schroeter et al., 2008; Schroeter et al., 2009). Underlying different
etiologies and pathomechanisms (Finder, 2010; Rabinovici and
Miller, 2010), AD and FTLD have been related to speciﬁc metabolic
and atrophic brain changes. MRI provides information about gray
matter atrophy, whereas glucose metabolism is investigated with
FDG-PET. However, results of FDG-PET analyses may be biased by
gray matter atrophy if they are not corrected for partial volume
effects (PVE) (Rousset et al., 1998). Accordingly, the correction for
partial volume effects is a state-of-the-art step in preprocessing of
FDG-PET imaging data (see also Baete et al., 2004). Recently, PVE-
correction has been successfully applied when comparing atrophy
and hypometabolism in AD (Chetelat et al., 2008). Although one
study has investigated glucose metabolism and amyloid plaque
density in subjects with AD and semantic dementia (Drzezga et al.,
2008), to date, no study using FDG-PET has integrated other FTLD
subtypes into a PVE corrected group comparison.
Firstly, our study aimed at investigating differences in FDG metab-
olism and gray matter atrophy with regard to their localization, as
well as their extent in subjects suffering from AD or FTLD, using
data corrected for PVE. Second, we intended to contribute to the
external validation of the DemTect as a diagnostic tool capable of
detecting cognitive deﬁcits and linking them to morphological and
glucose metabolic changes in the brain. Although the DemTect has
already been conceptually validated as a sensitive and speciﬁc screen-
ing tool for AD by the use of FDG-PET as an in-vivo reference method
(Scheurich et al., 2005), and there are studies that have investigated
the neural networks involved in cognitive paradigms similar to
those used in the DemTect in healthy subjects and dementia patients
(Andreasen et al., 1995; Awh et al., 1996; Cabeza et al., 2002;
Demonet et al., 1992; Fiez et al., 1996; Grasby et al., 1993; Henson
et al., 2000; Jonides et al., 1998; Peters et al., 2009; Sato et al., 1999;
Schroeter et al., 2012; Smith and Jonides, 1997; Smith et al., 1996,
1998), no study has systematically examined the neural correlates
of the subtests of the DemTect. Accordingly, our study aimed to inves-
tigate the DemTect in relation to two neurodegenerative diseases (AD
and FTLD) using a multimodal imaging study including MRI andFDG-PET. We hypothesized that performance in the DemTect subtests
is associated with temporoparietal regions in AD and frontotemporal
regions in FTLD. After correlating DemTect scores with MRI and
FDG-PET data in the whole cohort to isolate the neural correlates of
this test per se, we combined results with group comparisons be-
tween AD or FTLD patients and the control cohort in a conjunction
analysis, and calculated disease-speciﬁc correlation analyses to iden-
tify neural correlates of the DemTect for AD and FTLD.2. Methods
2.1. Subjects
We included 48 right-handed subjects from age 40 to 74 (25 females,
23males), whowere admitted to the Clinic of Cognitive Neurology at the
University of Leipzig (Table 1; (Dukart et al., 2011)). They had presented
with complaints of cognitive and/or behavioral alterations, by their own
account and/or by the account of caregivers. Upon admittance, subjects
underwent a high-quality FDG-PET and structural MRI scan; a compre-
hensive neurological and psychiatric history and examination; neuropsy-
chological rating of behavioral deﬁcits (Hughes et al., 1982); and testing
of memory, executive function, attention and language. Details of the
test batteries involved in our assessment are described in Frisch et al.
(2013) and Schroeter et al. (2011, 2012). Inclusion criteriawere a diagno-
sis of either probable AD, according to the revised NINCDS–ADRDA
criteria (McKhann et al., 1984), FTLD, in accordance to criteria proposed
by Neary et al. (1998), or subjective cognitive impairment, characterized
by complaints of cognitive impairment that could not be conﬁrmed
by neuropsychological testing. The last group was chosen as a control
group (please see also Discussion). Patients were excluded if structural
imaging revealed lesions due to stroke, traumatic head injury, brain
tumor or inﬂammatory diseases. All data were acquired for diagnostic
purposes. Within the whole group, 29 subjects from age 40 to 74 (16
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of the DemTect-A (Table 1). We obtained informed consent from all pa-
tients. The research protocol was approved by the local ethics committee
and was in accordance with the Declaration of Helsinki.
2.2. Acquisition of neuroimaging data
2.2.1. MRI scanning
For each patient, a high resolution T1-MRI dataset was recorded
on a 3 T Siemens TRIO (Siemens, Erlangen, Germany) or a Bruker
Medspec 30/100 (Bruker, Ettlingen, Germany) scanner. Therefore
either a magnetization-prepared rapid gradient echo sequence or a
modiﬁed driven equilibrium Fourier transform imaging technique
was used, recording 128 anterior–posterior, commissure line adjusted
partitions in sagittal orientation and providing a spatial resolution of
1 × 1 × 1.5 mm (TR = 1300 ms, TI = 650 ms, TE = 3.93 ms, TE =
10 ms; FOV 25 × 25 respectively 25 × 24 cm; matrix = 256 × 256 or
256 × 240 voxels).
2.2.2. PET scanning
We conducted MRI and FDG-PET imaging within a period of a
few weeks from admittance. Patients fasted for one night before PET
imaging and were injected with 370 MBq of the radiotracer 18F-FDG
immediately before the scanning procedure, which was conducted
in 2-dimensional mode using a Siemens ECAT EXACT HR + PET
device (CTI/Siemens, Knoxville, TN, USA). A dynamic scan was
performed for 60 min under standard resting-state conditions with
eyes open, recording 63 transaxial slices simultaneously with an
axial resolution of 5 mm full width at half maximum (FWHM) and
an in-plane resolution of 4.6 mm. Each collected slice had a thickness
of 2.45 mm and a matrix size of 128 × 128 voxels. After correction
for attenuation, scatter, decay and scanner-speciﬁc dead-time, the
PET data were reconstructed by ﬁltered back-projection using a
Hann ﬁlter (4.9 mm full width at half maximum).
2.3. Preprocessing of neuroimaging data
Preprocessing was performed using the Statistical Parametric
Mapping software package (SPM5, www.ﬁl.ion.ucl.ac.uk/spm/) run
with Matlab 7.7 (The MathWorks Inc., Natick, MA). Data preprocess-
ing consisted of co-registration of FDG-PET and MRI data, segmenta-
tion of MRI data into different tissue classes (only the gray matter
tissue class is used for further analyses), convolution-based voxel-
wise PVE correction of FDG-PET data using the modiﬁed Müller–
Gärtner method (Müller-Gärtner et al., 1992; Rousset et al., 1998)
implemented in the PVElab software package (Quarantelli et al., 2004)
and spatial normalization using Diffeomorphic Anatomical Registration
Through Exponentiated Lie Algebra (DARTEL, Ashburner, 2007). The
PVE procedure uses the segmented MR images to account for PVE and
for potential atrophy effects in FDG-PET. The same deformation matri-
ces used to normalize gray matter images were applied to FDG-PET
images. Gray matter images were additionally modulated to
preserve the total amount of signal from each region. As modulated
gray matter maps identify differences in local volume they are
commonly considered as measurements of atrophy (Mechelli et al.,
2005). Non-gray matter voxels were masked before and after
smoothing. Smoothing was performed using a Gaussian kernel of
12 mm FWHM. FDG-PET data were normalized to cerebellar mean
uptake values (Dukart et al., 2010). Additionally, prior to smoothing,
we normalized all obtained images to Montreal Neurological Institute
(MNI) space using afﬁne only transformations. We retrieved anatomical
descriptions of correlating brain regions by consensus, supported by
FSLView 3.1 software (http://www.fmrib.ox.ac.uk/fsl/fslview/index.
html). The obtained modulated and smoothed gray matter probability
maps are further referred to as MRI data.2.4. Statistical analysis
We performed group comparisons for demographic and clinical
characteristics, as well as the transformed (age-adjusted) DemTect
subscores, in SPSS 19.0 (http://www-01.ibm.com/software/de/analytics/
spss/) by means of an analysis of variance (ANOVA) and two-tailed
chi-square tests (p b 0.05). Post-hoc analyses were performed with
two-tailed post-hoc t-tests (p b 0.05 Bonferroni-corrected for multiple
comparisons).
A voxel-based whole brain analysis of all 48 subjects' FDG-PET and
MRI data was applied for group comparisons of the AD and FTLD
patients, and the control subjects. Age and sex were included as
covariates in all analyses (Kalpouzos et al., 2009). MR scanner types
and sequences were not included as covariates because their distribu-
tion of use was even across subjects and did not differ signiﬁcantly
between diagnostic groups (Dukart et al., 2011). Results were displayed
as t-maps. The extension of hypometabolic and atrophic brain regions
for different contrasts was calculated by the sum of all clusters (in
voxels) exceeding an uncorrected threshold of p b 0.001 on the voxel
level and p b 0.05 (corrected) on the cluster level.
After the group comparisons, we conducted whole brain corre-
lation analyses between the neuroimaging data and the subscores
of the DemTect in the 29 patients with neuropsychological test
scores. We included patients with neurodegenerative dementia of
different etiology (AD and FTLD), as well as control subjects, to
gain a high variance in correlation analyses, as suggested in previ-
ous studies (Schroeter et al., 2011, 2012). In this subgroup, age,
type of scanner, and protocol were added as covariates in the
MRI analyses to correct for an unequal distribution between
diagnostic groups. Results were displayed as t-maps. A threshold
of p b 0.001 on voxel-level and of p b 0.05 (corrected) on cluster-
level was administered.
Finally, we conducted a conjunction analysis relating the neural
correlates of the DemTect subscores across the different diagnostic
groups to the speciﬁcally impaired brain regions in AD and FTLD, for
glucose utilization and gray matter density. Moreover, to draw further
disease-speciﬁc conclusionswe conducted a correlation analysis within
the dementia subgroups under the same conditions mentioned for the
correlation analysis across diagnostic groups.3. Results
3.1. Analysis of demographic and clinical data
Demographic and clinical data for the whole group involved in the
group comparison, and for the DemTect subgroup involved in the corre-
lation analysis, are described in Table 1. If there were category-speciﬁc,
signiﬁcant, between-group effects in an ANOVA, post-hoc t-tests
were carried out (Bonferroni-corrected for multiple comparisons, sig-
niﬁcance threshold p b 0.05, based on directed hypotheses one-tailed
p for comparisons of dementia subgroups vs. control group for Clinical
Dementia Rating (CDR)-score, DemTect scores and MMSE score, for
age two-tailed p reported).
For the whole group, signiﬁcant group differences in age could be
shown between the AD and control subgroups, and between the FTLD
and control subgroups, whereas there were no differences between
the AD and FTLD subgroups (AD vs. control: p = 0.008, t = 3.181,
df = 32; FTLD vs. control: p = 0.024, t = 2.861, df = 25; AD vs.
FTLD: p =1.000, t = −0.157, df = 33). In the DemTect group, a
signiﬁcant difference in age could be shown between the AD and
control subgroups, but not between the other subgroups (AD vs. control:
p = 0.029, t =2.767, df = 18; FTLD vs. control: p = 0.154, t = 2.064,
df = 13; AD vs. FTLD: p = 1.000, t = −0.669, df = 21). Accordingly,
age was included as a covariate in the subsequent analyses of imaging
data.
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both dementia subgroups for both, the whole group (AD vs. control:
p b 0.001, t = 5.357, df = 32; FTLD vs. control: p b 0.001, t = 4.347,
df = 25; AD vs. FTLD: p = 0.977, t = 0.942, df = 33) and for the
DemTect group (AD vs. control: p = 0.001, t = 3.888, df = 18; FTLD
vs. control: p b 0.001, t = 4.266, df = 13; AD vs. FTLD: p = 1.000,
t = 0.762, df = 21). As expected, in thewhole groupMMSEwas higher
in controls than in both dementia subgroups; signiﬁcant differences
could be shown particularly between AD and control subgroups
(AD vs. control: p = 0.008, t = −3.143, df = 23; FTLD vs. control:
p = 0.055, t = −2.298, df = 14; AD vs. FTLD: p = 1.000, t = 0.809,
df = 29). For the DemTect group, no signiﬁcant MMSE differences
were observed between subgroups (probably due to reductions in sta-
tistical power), however the mean values showed the same descriptive
differences.
The DemTect sum score and subscores for the three cohorts are
reported in Table 1. In accordance with the hypothesis, the DemTect
sum score was higher in the control group than in the patients
with dementia syndromes (AD vs. control: p = 0.002, t = −4.831,
df = 18; FTLD vs. control: p = 0.002, t = −3.155, df = 13; AD vs.
FTLD: p = 1.000, t = −0.274, df = 21). Group comparisons in the
DemTect subtests revealed lower scores in both dementia groups in
comparison with the control subjects for the “wordlist” subtest with no
differences between AD and FTLD (AD vs. control: p = 0.038,
t = −3.184, df = 18; FTLD vs. control: p = 0.016, t = −3.328, df =
13; AD vs. FTLD: p = 1.000, t = −0.640, df = 21). Signiﬁcant differ-
ences between both dementia groups and control subjects were also
observed for “wordlist, delayed recall” (AD vs. control: p b 0.001,
t = −3.831, df = 5.8; FTLD vs. control: p = 0.017, t = −2.079, df =
13; AD vs. FTLD: p = 0.654, t = 1.128, df = 9.5) and for the “supermar-
ket task” (AD vs. control: p = 0.001, t = −6.752, df = 13; FTLD vs.
control: p b 0.001, t = −6.364, df = 8; AD vs. FTLD: p = 0.516,
t = −1.262, df = 21). There were no between-group effects for the
subtests “number transcoding” and “digit span reverse”.
In summary, dementia cohorts were characterized by lower
MMSE/DemTect sum scores and three of the ﬁve DemTect subtest
scores, and higher CDR scores in comparison with control subjects.
Remarkably, we did generally not ﬁnd statistical signiﬁcant differences
between dementia cohorts and relatively low impairment in both
dementia groups indicating comparable stages of early dementia.
3.2. Group comparison between AD, FTLD and control subjects
Results for the comparisons of glucose metabolism and gray
matter density between groups are illustrated in Fig. 1. Voxel-based
group comparisons showed bilateral parietotemporal, retrosplenial
and left-hemispheric prefrontal hypometabolic and atrophic regions
in AD compared to control subjects. FTLD subjects had a lower glucose
metabolism than control subjects in the bilateral prefrontal, left tempo-
ral and parieto-occipito-temporal junction regions. In the same contrast
for MRI, we further observed gray matter atrophy in a bilateral, mainly
left-sided prefrontal and a large lefthemispherial temporal region.
Subjects with AD showed reduced glucose metabolism in bilateral
retrosplenial cortex compared to FTLD subjects.
We consecutively calculated the sum of all signiﬁcant clusters
(in voxels) found in group comparisons (Fig. 1). We observed substan-
tiallymore pronounced graymatter atrophy in FTLD than in ADpatients
when comparing them to control subjects. In contrast, hypometabolism
wasmore pronounced in AD than in FTLD patients, bothwhen compar-
ing them to control subjects and when comparing them directly with
each other. In the comparison AD vs. control subjects, hypometabolism
extended gray matter atrophy. Gray matter atrophy extended
hypometabolism if FTLD was compared with control subjects. In AD
vs. FTLD we found no signiﬁcant gray matter atrophy. No signiﬁcant
differences in the extent of gray matter atrophy or hypometabolism
could be found in the contrast FTLD vs. AD.3.3. Correlation of performance inDemTect subtestswith glucosemetabolism
and gray matter density across diagnostic groups
Fig. 2 and Tables 2 & 3 show the results of the correlation analysis.
In the following, we describe the results for each DemTect subtest
score separately.3.3.1. Wordlist
Impairment in the “wordlist” subtest (sum of both trials) was
associated with lower glucose metabolism in the left superior and
middle temporal gyrus. Evaluation of the ﬁrst trial (not displayed)
revealed a correlation in the same regions but spreading further to the
left angular gyrus and the temporal pole. No results were obtained for
correlation with gray matter density.3.3.2. Number transcoding
Impairment in “number transcoding” subtest was signiﬁcantly
correlated with hypometabolism in a left lateralized network includ-
ing the middle and inferior temporal gyri, the posterior angular gyrus,
the middle occipital gyrus, parts of the middle and inferior frontal
gyrus, the posterior and lateral orbital gyrus, the putamen and the
head of caudate nucleus. There was also a signiﬁcant correlation in the
right middle temporal gyrus. Furthermore we could show a correlation
with gray matter density in the right angular gyrus and adjacent poste-
rior, superior and middle temporal gyri, bilaterally in the posterior
inferior precuneus, the dorsal posterior cingulate, the retrosplenial
cortex, the left inferior frontal gyrus, parts of the lateral sulcus, the
head of caudate nucleus, the putamen and the anterior insular cortex.3.3.3. Supermarket task
Impairments in the semantic word ﬂuency subtest (“supermarket
task”) did not correlate with either hypometabolism or gray matter
density at the chosen signiﬁcance threshold.3.3.4. Digit span reverse
Impairments in the “digit span reverse” subtest correlated with
hypometabolism in the left frontal cortex (including the superior, mid-
dle and inferior frontal gyri, the frontomedian cortex, the gyrus rectus
and themedial and anterior orbital gyri), and bilaterally in the putamen,
the heads of the caudate nucleus and the anterior insula. No signiﬁcant
results were obtained for correlation with gray matter density.3.3.5. Wordlist, delayed recall
Impairments in the “wordlist delayed recall” subtest were associated
with hypometabolism in the left middle and superior temporal gyri and
posterior temporal sulcus. Again, no signiﬁcant results were obtained for
correlation with gray matter density.3.4. Conjunction analysis
The ﬁrst analysis compared glucose utilization and gray matter atro-
phy in the dementia syndromes AD and FTLD with the control group,
whereas the second correlation analysis related test performance in the
DemTect's subtests to both of the imaging measures taken, across the
whole cohort. Finally, a conjunction analysis between both analyses
aimed to relate results of the DemTect correlation to the dementia sub-
groups AD and FTLD. Fig. 3 shows almost similar results for glucose utili-
zation, whereas gray matter atrophy was related to performance in the
“number transcoding” subtest differently in AD and FTLD, in particular
to graymatter atrophy in the retrosplenial/precuneal/posterior cingulate
cortex and the right posterior middle temporal gyrus in AD, and to atro-
phy in the left anterior insula, the caudate head and the putamen in FTLD.
Fig. 1. A: Reductions in glucose utilization (red) and gray matter density (blue) in dementia syndromes in comparison with control subjects and each other, rendered onto MNI
template. Overlap is in purple. Only clusters with p b 0.05 (corrected) are displayed. Color spectrum represents t values. Left is left. B: The bar chart illustrates the extension of
hypometabolic and atrophic brain regions (sum of all clusters in voxels exceeding an uncorrected threshold of p b 0.001 on the voxel level, and p b 0.05 corrected on the cluster
level). AD = Alzheimer's disease, C = control subjects, FTLD = frontotemporal lobar degeneration, MNI = Montreal Neurological Institute, n.s. = not signiﬁcant.
Fig. 2. Correlation between DemTect raw scores and glucose utilization (red-yellow) and gray matter density (blue) rendered onto MNI template. Only clusters with p b 0.05
(corrected) are displayed. Color spectrum represents t values. Left is left. MNI = Montreal Neurological Institute.
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Table 2
Correlation between glucose metabolism and DemTect raw scores across diagnostic groups.
Anatomical regions Lat. Coordinates T score Z score Cluster size
x y z
Wordlist
Left superior and middle temporal gyrus (BA 21/22) L
L
L
−62
−57
−48
−34
−15
−27
−4
−10
0
6.14
5.32
4.94
4.79
4.34
4.11
16,396***
Number transcoding
Left inferior and middle temporal gyrus (BA 20/21) L
L
L
−65
−59
−49
−35
−17
−48
−4
−30
−13
6.03
4.55
4.54
4.73
3.87
3.86
14,356***
Left posterior angular gyrus, BA 39, middle occipital gyrus (BA 19) L
L
L
−43
−38
−44
−51
−57
−61
31
22
51
5.80
5.29
5.25
4.60
4.32
4.30
11,135**
Left middle frontal gyrus (BA 9/46) L
L
L
−33
−33
−42
12
35
26
37
43
34
4.93
4.33
3.96
4.11
3.72
3.47
4798*
Right middle temporal gyrus (BA 21) R
R
R
51
39
53
−41
−36
−32
−7
−12
−9
4.88
4.69
4.45
4.07
3.96
3.80
4844*
Left putamen and head of caudate nucleus, left inferior frontal gyrus,
pars orbitalis and triangularis, anterior, posterior and lateral
orbital gyrus (BA 11–13/45–47)
L
L
L
−21
−36
−43
11
37
35
7
−6
3
4.60
4.57
4.39
3.90
3.88
3.76
17,307***
Supermarket task
No signiﬁcant suprathreshold clusters
Digit span reverse
Left superior, middle and inferior frontal gyrus (BA 20/21),
frontomedian cortex (BA 9/10/32), anterior insula
(BA 15–16), putamen and head of caudate nucleus
L
L
L
−34
−43
−55
9
19
33
58
35
9
7.26
5.56
5.08
5.32
4.47
4.20
45,506***
Right putamen and head of caudate nucleus, anterior insula (BA 15–16) R
R
R
23
18
27
18
27
29
5
1
11
4.85
4.76
4.71
4.06
4.00
3.97
6717*
Left frontal pole (BA 10/11), left gyrus rectus,
medial and anterior orbital gyrus
L
L
L
−28
−16
−28
63
37
57
−5
−22
20
4.27
4.22
4.19
3.68
3.65
3.63
7379**
Wordlist (delayed recall)
Left middle and superior temporal gyrus (BA 21/22),
left posterior temporal sulcus
L
L
L
−53
−46
−60
−14
−48
−33
−7
8
−10
4.92
4.17
4.12
4.10
3.61
3.58
6887*
Note. Age included as covariate. Cluster size in voxels, voxel size = 1 × 1 × 1 mm. p (voxel-level uncorrected) b 0.001. *p b 0.05, **p b 0.01, ***p b 0.001, corrected for multiple
comparisons on cluster-level. Cluster size threshold of 30 voxels. Coordinates in MNI space. BA = Brodmann area, Lat. = laterality, L = left, R = right.
Table 3
Correlation between gray matter density and DemTect raw scores across diagnostic groups.
Anatomical regions Lat. Coordinates T score Z score Cluster size
x y z
Wordlist
No signiﬁcant suprathreshold clusters
Supermarket task
No signiﬁcant suprathreshold clusters
Number transcoding
Right angular gyrus (BA 39), posterior superior
and middle temporal gyrus (BA 22/37)
R
R
R
56
60
49
−53
−46
−40
21
9
23
6.57
6.51
4.75
4.92
4.89
3.95
8931**
Bilateral posterior inferior precuneus (BA 7/31),
dorsal posterior cingular cortex (BA 23, 31)
and retrosplenial cortex (BA 30)
R
L
L
8
−11
−2
−57
−56
−59
32
26
33
6.23
5.65
5.45
4.76
4.46
4.35
10,168**
Left inferior frontal gyrus, pars opercularis (BA 44),
triangularis (BA 45) and orbitalis (BA 47), pars
ascendens and horicontalis of lateral sulcus, head
of caudate nucleus, putamen, anterior insular
cortex (BA 15/16), posterior orbital gyrus (BA 12, 47)
L
L
L
−42
−12
−28
11
3
4
13
7
12
4.48
4.44
4.43
3.78
3.75
3.75
11,967**
Digit span reverse
No signiﬁcant suprathreshold clusters
Wordlist (delayed recall)
No signiﬁcant suprathreshold clusters
Note. Age, scanner type and protocol included as covariates. Cluster size in voxels, voxel size = 1 × 1 × 1 mm. p (voxel-level, uncorrected) b 0.001. **p b 0.01, corrected for
multiple comparisons on cluster-level. Cluster size threshold of 30 voxels. Coordinates in MNI space. Lat. = laterality, L = left, R = right.
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Fig. 3. Conjunction analysis for group comparisons (patients with dementia syndromes vs. control subjects) and correlation analysis of the DemTect subscores rendered onto MNI
template. A: Conjunction analysis for AD b control subjects. B: Conjunction analysis for FTLD b control subjects. Glucose utilization (red) and gray matter density (blue). Only clus-
ters with p b 0.05 (corrected) are displayed. Left is left. AD = Alzheimer's disease, FDG-PET = F-18-ﬂuorodeoxyglucose positron emission tomography, FTLD = frontotemporal
lobar degeneration, MNI = Montreal Neurological Institute, MRI = magnetic resonance imaging.
752 T.B. Woost et al. / NeuroImage: Clinical 2 (2013) 746–7583.5. Correlation of performance inDemTect subtestswith glucosemetabolism
and gray matter density within the dementia subgroups
Fig. 4 and Tables 4 & 5 show the results of the correlation analysis
within the two dementia subgroups. In the following, we describe the
results for AD and FTLD separately.
3.5.1. AD
In the AD sample we detected correlates between performance in
the wordlist task and glucose metabolism in the left superior temporal
gyrus. No correlates concerning other tests or gray matter density
could be shown.
3.5.2. FTLD
In the FTLD group, we detected correlates both concerning glucose
utilization and atrophy. In the “number transcoding” subtest, perfor-
mance was associated with gray matter density bilaterally in the
angular gyrus and rectal gyrus, and in the right superior temporal
sulcus. For the “digit span reverse” task we found neural correlates
for glucose metabolism in the posterior left middle frontal gyrusand correlates for gray matter density in the posterior right middle
frontal gyrus.
4. Discussion
In our study, we aimed to identify regional hypometabolism and
gray matter atrophy in AD and FTLD patients using PVE corrected
data. Based on these data, we intended to discover the neural corre-
lates of performance in the DemTect with multimodal imaging. Note
that both dementia cohorts involved clinically comparable early
stages of the disease as shown by similar CDR, MMSE and DemTect
scores.
Concerning the inclusion of subjects with subjective cognitive im-
pairment as a control group in our study, one could raise the point
that this potentially would not be a healthy population, as there are
several studies in individuals with subjective memory impairment
showing a progression to mild cognitive impairment or dementia
(e.g. Heun et al., 2006; Luck et al., 2010; Scheef et al., 2012; van
Harten et al., in press). Hence, such a control group with subjective
cognitive impairment could potentially reduce the extent of
Fig. 4. Correlation between glucose utilization (red-yellow)/gray matter density (blue) and DemTect raw scores within dementia subgroups rendered onto MNI template. Only clus-
ters with p b 0.05 (corrected) are displayed. Color spectrum represents t values. Left is left. A: Correlation between DemTect raw scores and glucose utilization/gray matter density
in AD. B: Correlation between DemTect raw scores and glucose utilization/gray matter density in FTLD. AD = Alzheimer's disease, FTLD = frontotemporal lobar degeneration,
MNI = Montreal Neurological Institute.
Table 5
Correlation between gray matter density and DemTect raw scores in dementia
subgroups.
Anatomical regions Lat. Coordinates T Z Cluster size
753T.B. Woost et al. / NeuroImage: Clinical 2 (2013) 746–758conclusions that can be drawn from comparisons with AD and FTLD
subjects. Nevertheless, we think that such a control group is justiﬁed
and actually has several advantages in comparison with healthy
subjects: First, memory or cognitive complaint is also known to
occur in healthy aging as a discrepancy between demands and normal
decline of cognitive abilities (see also Frisch et al., 2013). In
recent studies, cognitive complaint could not differentiate between
memory-declining and cognitively normal older adults and it could
not be shown as a predictor for the development of dementia (Mol
et al., 2006; Weaver Cargin et al., 2008). In our control subjects,
mild cognitive impairment or dementia were excluded by thorough
examination, neuropsychological testing and comprehensive multi-
modal neuroimaging with MRI and FDG-PET. These subjects with
subjective cognitive impairment did not show abnormalities onTable 4
Correlation between glucose metabolism and DemTect raw scores in dementia
subgroups.
Anatomical regions Lat. Coordinates T
score
Z
score
Cluster
size
x y z
AD
Wordlist
Left superior temporal
gyrus (BA 22)
L
L
−55
−46
−14
−7
−1
−13
5.49
4.97
3.73
3.53
3909*
Number transcoding No signiﬁcant suprathreshold clusters
Supermarket task No signiﬁcant suprathreshold clusters
Digit span reverse No signiﬁcant suprathreshold clusters
Wordlist (delayed recall) No signiﬁcant suprathreshold clusters
FTLD
Wordlist No signiﬁcant suprathreshold clusters
Number transcoding No signiﬁcant suprathreshold clusters
Supermarket task No signiﬁcant suprathreshold clusters
Digit span reverse
Left posterior middle
frontal gyrus (BA 9)
L −35 18 56 12.77 4.34 2785**
Wordlist (delayed recall) no signiﬁcant suprathreshold clusters
Note. Age included as covariate. Cluster size in voxels, voxel size = 1 × 1 × 1 mm.
p (voxel-level uncorrected) b 0.001. *p b 0.05, **p b 0.01, corrected for multiple
comparisons on cluster-level. Cluster size threshold of 30 voxels. Coordinates in MNI
space. AD = Alzheimer's disease, BA = Brodmann area, FTLD = frontotemporal
lobar degeneration, Lat. = laterality, L = left, R = right.relevant measures compared to age-matched healthy cohorts. Note
that normal imaging ﬁndings in our control cohort with subjective cog-
nitive impairment make beginning AD very unlikely, because a recent
study has shown precuneal hypometabolism and hippocampal atrophy
already in persons with subjective memory impairment (Scheef et al.,
2012). Second, the differentiation between patients with subjective
cognitive impairment and patients with dementia syndromes is most
important in clinical practice (Dukart et al., 2010, 2011; Schroeter et
al., 2011). Third, for ethical reasons (exposure to radiation) FDG-PETscore score
x y z
AD
No signiﬁcant suprathreshold clusters
FTLD
Wordlist No signiﬁcant suprathreshold clusters
Supermarket task No signiﬁcant suprathreshold clusters
Number transcoding
Right angular gyrus
(BA 39)
R
R
R
53
57
48
−49
−50
−41
22
30
26
31.24
28.96
8.05
4.52
4.45
3.22
2486***
Right superior
temporal sulcus
(BA 21/22)
R
R
R
48
42
42
−32
−34
−38
−4
6
13
20.39
10.22
8.56
4.14
3.47
3.28
901**
Left angular gyrus
(BA 39)
L
L
−40
−54
−63
−61
33
46
17.45
7.95
4.00
3.20
686*
Bilateral gyrus rectus
(BA 11)
R
L
L
1
−12
−4
33
40
47
−26
−25
−19
16.47
13.76
7.77
3.95
3.77
3.18
1290**
Digit span reverse
Right posterior middle
frontal gyrus (BA 9)
R
R
R
37
41
41
18
11
19
41
58
54
135.22 5.63 1221**
Wordlist (delayed recall) No signiﬁcant suprathreshold clusters
Note. Age, scanner type and protocol included as covariates. Cluster size in voxels,
voxel size = 1 × 1 × 1 mm. p (voxel-level, uncorrected) b 0.001. *p b 0.05, **p b 0.01,
***p b 0.001, corrected for multiple comparisons on cluster-level. Cluster size threshold of
30 voxels. Coordinates in MNI space. AD = Alzheimer's disease, FTLD = frontotemporal
lobar degeneration, Lat. = laterality, L = left, R = right.
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emphasize that our control cohort consisted of individuals with subjec-
tive cognitive impairment reporting complaints in one or more of all
possible cognitive domains (memory, attention, executive functions)
and not only memory such as in subjective memory complainers.
Hence, our control cohort does not show a speciﬁc pattern of subjective
complaints possibly indicating prestages of Alzheimer's disease and
exhibits rather unspeciﬁc subjective complaints. Furthermore, note
that in our group comparisons between FTLD or AD patients and control
subjects the same control groupwas involved,making systematic biases
very unlikely. We hold the view that – due to the mentioned reasons –
in the context of our study sufﬁcient conclusions can be drawn from
subjects seeking for diagnostic evaluation of subjective cognitive
complaint. Accordingly, we consider subjects with subjective cognitive
impairment not only an acceptable, but also an ideal control group
from a clinical point of view. There are several current studies including
subjects with subjective cognitive impairment as a control group in the
literature (e.g. Schroeter et al., 2012).
We also want to discuss an interesting point of our analysis of
clinical data. As described we did generally not ﬁnd signiﬁcant differ-
ences between performances of AD and FTLD groups in the subtests of
the DemTect. However, on a descriptive level the DemTect subscores
show subtle differences between AD and FTLD, which are generally in
accordance with the traditional concept of neuropsychological pro-
ﬁles of these diseases (see for example Thompson et al., 2005): AD
subjects performed worse than FTLD subjects in delayed recall of
the wordlist, a ﬁnding which would be predicted by several studies
assuming a poorer memory consolidation in AD. In contrast, AD
subjects performed better in the supermarket task and in digit span
reverse, which could partly be related to frontal lobe functions
which have been assumed to be more impaired in FTLD (at least
FTD). We cannot exclude that the absence of signiﬁcant subscore
differences between the groups is due to the relatively small number
of subjects and the heterogeneity of the FTLD cohort. Nevertheless,
these ﬁndings are also in correspondence with recent data in the
literature. These studies question the speciﬁcity of the neuropsycho-
logical proﬁle for both neurodegenerative diseases, rather showing
overlapping deﬁcits for instance for memory and executive functions
(see meta-analysis by Hutchinson and Mathis, 2007; and Frisch et al.,
2013; Schroeter et al., 2012). This has been discussed in the context
of large distributed networks contributing to the different cognitive
functions which break down in dementing illnesses (see Sporns, 2010
among others for an overview).
4.1. Dissociation between atrophy and hypometabolism in FTLD and AD
In our study, we performed group comparisons between AD, FTLD
and control subjects with subjective cognitive impairment using a mor-
phometric approach. Results for the group comparisons were in agree-
ment with previous studies, showing mainly impaired parietotemporal
networks, including the posterior cingulate cortex for AD (Barnes et al.,
2007; Baron et al., 2001; Boxer et al., 2003; Buckner et al., 2005;
Chetelat et al., 2008; Frisoni et al., 2002; Rabinovici et al., 2007;
Schroeter et al., 2009; Seeley et al., 2009) and alterations in mainly ante-
rior frontotemporal regions, including the anterior cingulate cortex for
FTLD, when compared to healthy subjects (Barnes et al., 2007; Boxer et
al., 2003; Chetelat et al., 2008; Desgranges et al., 2007; Ishii et al., 1998;
Jeong et al., 2005; Mummery et al., 2000; Rabinovici et al., 2007; Rosen
et al., 2002; Schroeter et al., 2008, 2011; Seeley, 2010; Seeley et al.,
2009). In both cases, alterations occurred predominantly in the left
hemisphere and included parts of the basal ganglia. Most interestingly,
metabolic decline appeared greater thangraymatter loss inADcompared
to control subjects, whereas the opposite was the case in the FTLD cohort
(see Fig. 1).
For AD, this is consistentwith previous ﬁndings (Chetelat et al., 2008)
and attributable to the fact that the metabolic decline is known toantecede morphological decline in the course of AD (Jack et al., 2010).
Apart from cytoplasmic inclusions of neuroﬁbrillary tangles due to ag-
gregation of hyperphosphorylated tau protein, the extracellular accumu-
lation of beta-amyloid has been discussed to play an important role in
initiating synaptic dysfunction, which may represent the main cause of
hypometabolism in FDG-PET (Chetelat et al., 2008; Jack et al., 2010).
The localization of these beta-amyloid deposits has been investigated
in several studies and supports the correctness of hypometabolic regions
in our AD cohort (Barthel et al., 2011; Forsberg et al., 2008; Kemppainen
et al., 2006; Klunk et al., 2004; Li et al., 2008; Rowe et al., 2007). Histo-
pathological correlates of FTLD differ from those of AD, including three
different types of cytoplasmic inclusions – FTLD-tau, FTLD-TDP43 and
FTLD-FUS due to a number of possible mutations, especially in the tau
and the progranulin gene (Rabinovici and Miller, 2010). However, the
exact succession of pathological changes has not yet been elucidated
satisfactorily. Our results may hint on pathomechanisms in FTLD, with
gray matter loss being less dependent on a wide-ranging decline of glu-
cose metabolism. Multimodal follow-up studies investigating different
stages of FTLD and its subtypes might provide further answers to this
question.
Interestingly, we did not observe differences concerning atrophy in
direct comparison of AD and FTLD in our study. This missing ﬁnding
might be related to early disease stage for both dementia subgroups,
the heterogeneity of the FTLD cohort and correction of imaging data
for multiple comparisons, ﬁnally leading to insufﬁcient statistical
power. However, there are signiﬁcant differences comparing AD and
FTLD groups directly with respect to FDGmetabolism in typical regions
(precuneus) underlining the relevance of FDG-PET for early diagnosis
and differential diagnosis of dementia syndromeswith a higher reliabil-
ity than MRI (Dukart et al., 2011). As PET data was corrected for partial
volume effects, one would even expect larger clusters in uncorrected
data.
4.2. Neural correlates of performance in DemTect subtests
The second focus of our study was the correlation between de-
mentia speciﬁc networks and performance in the DemTect's subtests.
Correlation analyses ﬁrstly were performed across diagnostic groups
with early dementia syndromes and including control subjects to
increase variances in exploring the neural correlates of the DemTect
as a screening instrument in early dementia. The same approach was
used likewise in several other studies to increase statistical power
(Rankin et al., 2006; Rosen et al., 2005; Schroeter et al., 2012). The
dilemma between disease speciﬁcity and statistical power could be
solved in the future by recruiting very large patient groups, and inves-
tigating patients with a further progression of disease. Nevertheless,
we also performed a correlation analysis within the relatively small
dementia subgroups to draw further disease-speciﬁc conclusions.
In our correlation analyses across diagnostic groups, we could char-
acterize functional neural correlates using FDG-PET in four out of the
ﬁve subtests. Further, for one subtest, structural neural correlates
were established. The DemTect's subtests examine the cognitive
domains of verbal short term memory and learning, processing of
language and numbers in combination with executive functions,
semantic word ﬂuency, verbal working memory and verbal long term
memory. In the following we discuss results for each of the DemTect's
subtests.
The “wordlist” paradigmwith immediate recall (sum of two trials)
is applied to detect impairments in auditory verbal short-termmemory
(Kessler et al., 2010) and learning. Impairments in explicit memory are
known as a striking clinical sign of AD in particular, whereas impair-
ment of language processing plays an important role in FTLD. In our
groups of early AD and FTLD subjects, performance in this task was
signiﬁcantly impaired compared to healthy subjects. The correlation
analysis with the scores of the wordlist subtest and imaging data iden-
tiﬁedmetabolic correlates in the left medial and superior temporal gyri,
755T.B. Woost et al. / NeuroImage: Clinical 2 (2013) 746–758including Wernicke's Region (BA 22). Concerning the ﬁrst trial of this
subtest (not displayed), these areas spread slightly to the angular
gyrus and the temporal pole. These regions have been related to audito-
ry,memory and language information processing (Sato et al., 1999) and
our results support prior ﬁndings about the neural correlates of verbal
span in short-term memory in AD subjects (Collette et al., 1997;
Desgranges et al., 1998). Posterior parts of the predominantly left
temporal lobe have been discussed to play a role in recoding visual into
phonological verbal material (Henson et al., 2000), the left temporal
pole, the posterior temporal lobe and the angular gyrus are mentioned
in the context of semantic processing of verbal items (Price et al.,
1997). Although there also are other regions known to be related to ver-
bal recall in healthy subjects, such as the anterior cingulate cortex (BA 24,
BA 32), the hippocampus, and the prefrontal cortex (BA 9, BA 10), in the
case of supraspan tasks (Baron et al., 2001), and in AD for example parts
of frontal and parietal lobes, putamen and posterior cingulate gyrus
(Desgranges et al., 1998), an involvement of these regions could not be
shown in our cohort. The “wordlist, delayed recall” subtest is designed
to address auditory verbal long term memory (Kessler et al., 2010).
Our correlates in regions similar to, but smaller than those in the imme-
diate recall, support the assumption that short-term memory strongly
limits long-term performance, as has been discussed in the literature
for a long time (Atkinson and Shiffrin, 1968; Baddeley et al., 1988).
The cognitive functions needed for the “number transcoding”
subtest are cognitive ﬂexibility, reading, writing and number pro-
cessing (Kessler et al., 2010), suggesting a large neural network.
One region, which emerged with a correlation in gray matter loss,
included the precuneus, the retrosplenial cortex and the posterior
cingulate cortex. The precuneus, which fulﬁlls different integrative
functions, has been proposed to be divided into heterogeneous
anatomical and functional subregions (Cavanna and Trimble, 2006;
Margulies et al., 2009) — an anterior region is involved in sensori-
motor processes, a central region is involved in cognitive processes
and a posterior region is involved in visual integrative processes.
Functional resting-state connectivity analyses (Margulies et al., 2009)
have previously shown connections between the central (cognitive)
parts of the precuneus and the angular gyrus, as well as dorsal pre-
frontal areas, a network that is identiﬁed also in our study. Moreover,
the precuneus, concerted with the posterior cingulate/retrosplenial
cortex, the predominantly left-lateralized lateral parietal cortex and a
frontal region near premotor cortex, have been discussed as parts of
the memory retrieval network (Buckner et al., 2005). As for the angu-
lar and supramarginal gyrus, their integrative involvement in reading,
writing and mathematical processes has been known for long time
(Seghier, 2013). Interestingly, we not only observed metabolic
correlates in the left hemisphere, but also correlates with atrophy in
the right hemisphere. We also found an involvement of the occipital
cortex, which is explainable by the necessity of integration of visually
presented material. Metabolic correlates in the temporal lobe account
for verbal processing, as already discussed for the wordlist subtest.
The involvement of a prefrontal dorsolateral network refers to the
involvement of verbal working memory (Baddeley, 1986). This has
also been observed in the “digit span reverse” subtest and is discussed
in the following section, as well as correlates of the anterior insula, the
putamen and the head of caudate nucleus.
“Digit span reverse” is a test which demands memorizing verbal
presentations of numbers and manipulating them in their order. This
is a typical function of working memory (Kessler et al., 2010) and
according to Baddeley (1986), of the so called phonological loop and
the central executive especially. As has been described by Smith and
Jonides (1997), the dorsolateral prefrontal cortex is involved in the
neural representation of verbal working memory. Moreover, this area
has been suggested to participate in retrieval, together with the inferior
frontal cortex, among other areas, and to play a role in storage of
phonologically coded verbal information (Jonides et al., 1998). As was
predictable for this task, we found metabolic correlates in thementioned regions.We also found correlates bilaterally in the putamen
and the head of caudate nucleus, in agreement with the proposed in-
volvement of the basal ganglia in learning and memory (Packard and
Knowlton, 2002). Furthermore, metabolic correlates were found in
the left and right anterior insula, known to be involved in auditory
and phonological processing (Bamiou et al., 2003).
The “supermarket task” subtest addresses cognitive ﬂexibility,
semantic word ﬂuency, cognitive speed and imaginative abilities
(Kessler et al., 2010). Recent studies have shown semantic or
categorial word ﬂuency to be related to hypometabolism in the left
prefrontal cortex, in particular the inferior frontal junction (Raczka et
al., 2010; Schroeter et al., 2012), the temporal and inferior frontal re-
gions, the fusiform gyrus, the posterior cingulate cortex, the middle oc-
cipital gyrus and the precuneus (Collette et al., 1997; Melrose et al.,
2009). Although dementia patients performed less efﬁciently in our co-
hort in comparison with control subjects (see Table 1), we did not de-
tect associations of performance with regional glucose metabolism or
gray matter atrophy on the chosen level of signiﬁcance. This absence
might be related to a very low variance in the control cohort, the diver-
sity of cognitive domains involved in this task, and the overrepresenta-
tion of early AD subjects in comparison with FTLD subjects that are
predominantly characterized by executive and language deﬁcits
(Raczka et al., 2010; Schroeter et al., 2012) ﬁnally leading to a low
signal-to-noise ratio.
Focusing on the DemTect as a screening instrument for different
diseases with dementia syndromes we may cautiously assume that
neural correlates of the DemTect correspond to typically impaired
regions both in AD and FTLD as illustrated by overlapping regions of
correlations and group comparison in a descriptive conjunction
analysis. In recent studies, the DemTect has been shown to be a highly
sensitive diagnostic tool for mild cognitive impairment, early AD,
dementia with Lewy bodies and vascular dementia (Kalbe et al., 2004;
Perneczky, 2003; Scheurich et al., 2005). Our conjunction analysis
shows wide overlaps with pathological patterns in both our AD and
FTLD cohort, especially concerning glucose metabolism, suggesting
the DemTect as an appropriate tool in the detection of both of these
dementia types. Interestingly, the conjunction of contrasts suggests
that hypometabolism in almost identical brain regions in both dementia
syndromes was correlated with the performance in the DemTect's
subtests, whereas for gray matter atrophy we observed a dissociation
between AD and FTLD in case of the number transcoding subtest. As
the shown conjunction of contrasts provides descriptive, though not
statistical results, we may very carefully assume that there are speciﬁ-
cally affected networks related to the DemTect performance in both dis-
eases, AD and FTLD. Although an involvement of quite comparable
neural networks in both diseases seems to be suggestive, a correlation
analysis within diagnostic groups allowed further conclusions about
disease-speciﬁc correlates and supports the hypothesis of different net-
works in both dementia cohorts driving the results of the analysis across
groups. Of most interest we could verify the correlates of performance
in the “wordlist” subtest from our approach across diagnostic groups
in the AD cohort. In AD subjects, we would traditionally expect prob-
lems with learning a wordlist due to deﬁcits in memory consolidation.
Correlates of the “number transcoding” and the “digit span reverse”
subtest could partly be veriﬁed in the FTLD cohort. In the “number
transcoding” subtest, we again observed the correlation of performance
with loss of graymatter density in the right angular gyrus. This was also
the case in the left angular gyrus, where we could only show correlates
with respect to glucosemetabolism in the correlation analysis across di-
agnostic groups. The results of our disease-speciﬁc correlation analysis
of the “digit span reverse” task verify the correlates of glucose metabo-
lism from analyses across diagnostic groups in the left dorsolateral fron-
tal lobe and additionally show correlates of gray matter density in the
contralateral area. These correlates ﬁt very well to the frontal lobe
functions that are required to solve this subtest and that are impaired
in FTLD.
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Although distinguishing between subjective cognitive impairment
and AD respectively FTLD subjects is of most clinical interest, the
inclusion of a subjective cognitive impairment cohort as a control
group might have reduced effects observed in the group comparisons
and could be seen as a weakness of this study with respect to recent
literature discussing subjective cognitive impairment as a prodromal
stage of mild cognitive impairment or dementia.
To perform a correlation analysis, it is important to investigate a
group exhibiting a preferably high variance. Accordingly, we decided
to involve patients with AD and FTLD, and control subjects and
performed correlation analyses across diagnostic groups to increase
statistical power as suggested previously (Rankin et al., 2006; Rosen
et al., 2005; Schroeter et al., 2011, 2012). Conclusions about disease-
speciﬁc correlates are limited by this approach, the illustration of
overlapping regions of the group comparison and the correlation
analysis across diagnostic groups in a conjunction analysis provides
descriptive, but not statistical information. Hence, disease-speciﬁc
conclusions should be drawn very cautiously at best. To further inves-
tigate different associated networks in the two dementia subgroups,
we conducted a correlation analysis within the dementia subgroups.
However, probably due to small sample sizes, we could not detect
all disease-speciﬁc correlates. Accordingly, our ﬁndings should be
seen as preliminary. Our study should be replicated within a larger
cohort to provide more information about the subtests of the
DemTect. We would also suggest correlation analyses within different
FTLD subtypes and of other neurodegenerative diseases with demen-
tia syndromes to further establish the DemTect as a screening instru-
ment for these diseases. Furthermore, it would be an interesting
approach in future studies to perform correlation analyses within di-
agnostic groups by inclusion of patients with different stages of de-
mentia syndromes to investigate the DemTect in rating the
progression of dementia syndromes.
5. Conclusion and perspectives
Using brain MRI and PVE-corrected brain FDG-PET data, our study
shows structural and functional neural correlates of the subtests of
the DemTect in two very frequent dementia syndromes — early AD
and FTLD. Results support an external validation of this frequently
used screening device. Interestingly, the DemTect's subtests did not
appear to correlate exclusively for AD, but also showed correlations
in regions known as typically afﬂicted in FTLD. Moreover, this study
contributes to a better understanding of cognitive impairments in
dementia on a neural level. In this sense, it may be conducive to facilitate
a stronger integration of neuroimaging ﬁndings in dementia diagnostic
criteria, as suggested previously. Finally we showed inversed relations
between gray matter loss and hypometabolism in AD and FTLD, hinting
at the pathomechanisms which are still not completely understood.
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